Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01530126 · ClinicalTrials.gov registry record · NA

Platelet Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain

A NA study of Periodontitis, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT01530126: Completed NA study of Periodontitis, sponsored by University of Michigan.

NCT01530126 is a NA study of Periodontitis that has completed, run by University of Michigan. The registered enrollment target is 180 participants, above the 99-participant average among 11 other Periodontitis trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01530126, a NA study of Periodontitis, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The aim of the study was to evaluate the safety and effectiveness of Platelet Derived Growth Factor (PDGF) mixed with b tricalcium phosphate (BTCP) for the treatment of advanced periodontal osseous defects at 6 months of healing.

Primary Outcome

Measurements for the rate of clinical attachment levels (CAL)

Conditions Studied

Interventions

  • BIOLOGICAL B-TCP + 0.3 mg/ml rhPDGF-BB in buffer
  • BIOLOGICAL B-TCP + 1.0 mg/ml rhPDGF-BB in buffer
  • BIOLOGICAL B-TCP +buffer

Study Locations (1)

Michigan

  • University of Michigan School of Dentistry - Ann Arbor

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2000-01
Est. Completion 2007-01
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01530126 record still lists

NCT01530126 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 99-participant average among 11 other Periodontitis trials with a reported enrollment target (82% higher).

The record links to 1 condition, with Periodontitis appearing as the primary indexed condition, and to 3 interventions - of which B-TCP + 0.3 mg/ml rhPDGF-BB in buffer is the first listed.

NCT01530126 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01530126 about?

NCT01530126 is a clinical study titled "Platelet Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain". The aim of the study was to evaluate the safety and effectiveness of Platelet Derived Growth Factor (PDGF) mixed with b tricalcium phosphate (BTCP) for the treatment of advanced periodontal osseous defects at 6 months of healing.

What is the current status of trial NCT01530126?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2000-01. Estimated completion is 2007-01.

What conditions does trial NCT01530126 study?

This clinical trial studies the following conditions: Periodontitis.

What interventions are being tested in trial NCT01530126?

The interventions under investigation include: B-TCP + 0.3 mg/ml rhPDGF-BB in buffer (BIOLOGICAL), B-TCP + 1.0 mg/ml rhPDGF-BB in buffer (BIOLOGICAL), B-TCP +buffer (BIOLOGICAL).

Who is sponsoring clinical trial NCT01530126?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01530126 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Periodontitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01530126's enrollment target sits among peer trials

180 1st of 11 higher than 11 of 11 other Periodontitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Periodontitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01530126, the US trial registry maintained by the National Library of Medicine. NCT01530126 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.